Article Text
Abstract
Statins are the Marmite (‘You either love it or hate it!’) of the drug world, both in terms of therapeutic benefit and risk of side effects. Proponents think that they are potential life-savers, opponents that their main benefit is lining the pockets of pharma. Some consider side effects to be a major issue, outweighing any therapeutic benefit, others that they are rare and essentially innocuous. Statin-induced myalgia is relatively common but often mild and for most people does not limit treatment. In others, reducing the dose or changing the preparation may help. In all, withdrawal of the statin leads to resolution. Statin-induced rhabdomyolysis, most often precipitated by drug–drug interaction, affects only a tiny proportion of statin users, but because of the widespread prescribing of statins is an important clinical problem. Statin-induced immune-mediated necrotising myopathy represents a novel disease mechanism and clinically mimics forms of myositis. Resolution often requires immunosuppressant drug treatment, as well as statin withdrawal.
- myopathy
Statistics from Altmetric.com
Footnotes
Funding This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent Not required.
Provenance and peer review Commissioned. Externally peer reviewed. This paper was reviewed by Simon Hammans, Southampton, UK.
Linked Articles
- Neurological rarities
Read the full text or download the PDF:
Other content recommended for you
- Investigating raised creatine kinase
- Statin-induced myopathy prevented by creatine administration
- Intensity of statin therapy and muscle symptoms: a network meta-analysis of 153 000 patients
- Exertional rhabdomyolysis: physiological response or manifestation of an underlying myopathy?
- Severe statin-induced autoimmune myopathy successfully treated with intravenous immunoglobulin
- Proximal myopathy: diagnostic approach and initial management
- Toxic and drug-induced myopathies
- Immune-mediated necrotising myopathy: a rare cause of hyperCKaemia
- Autoimmune necrotising myopathy and HMGCR antibodies
- Metabolic myopathies: a practical approach